T 1869/11 (Treatment of respiratory disorders/OCKHAM BIOTECH LIMITED) of 22.3.2013

European Case Law Identifier: ECLI:EP:BA:2013:T186911.20130322
Date of decision: 22 March 2013
Case number: T 1869/11
Application number: 03704789.1
IPC class: A61K 9/12
A61K 31/726
A61K 31/727
A61P 11/00
A61K 9/72
A61K 31/728
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 161.625K)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Use of glycosaminoglycans such as E.G. heparin for the treatment of respiratory disorders such as COPD
Applicant name: Ockham Biotech Limited
Opponent name: Vectura Limited
Board: 3.3.02
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 83
European Patent Convention Art 123(2)
European Patent Convention Art 111
Keywords: New main request - admission (yes)
Added matter (no)
Sufficiency of disclosure, novelty and inventive step (yes)
Remittal (no)


Cited decisions:
G 0002/08
T 0609/02
Citing decisions:
T 0394/11
T 1021/11
T 1823/11

11 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: I Patentability

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law